- Home
- GRWG vs SAVA Comparison
GRWG vs SAVA Comparison
Compare GRWG & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- SAVA
- Stock Information
- Founded
- GRWG 2008
- SAVA 1998
- Country
- GRWG United States
- SAVA United States
- Employees
- GRWG N/A
- SAVA N/A
- Industry
- GRWG RETAIL: Building Materials
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- GRWG Consumer Discretionary
- SAVA Health Care
- Exchange
- GRWG Nasdaq
- SAVA Nasdaq
- Market Cap
- GRWG 60.6M
- SAVA 70.5M
- IPO Year
- GRWG N/A
- SAVA N/A
- Fundamental
- Price
- GRWG $1.04
- SAVA $1.77
- Analyst Decision
- GRWG Buy
- SAVA Buy
- Analyst Count
- GRWG 4
- SAVA 3
- Target Price
- GRWG $2.38
- SAVA $54.50
- AVG Volume (30 Days)
- GRWG 567.4K
- SAVA 822.2K
- Earning Date
- GRWG 05-08-2025
- SAVA 05-08-2025
- Dividend Yield
- GRWG N/A
- SAVA N/A
- EPS Growth
- GRWG N/A
- SAVA N/A
- EPS
- GRWG N/A
- SAVA N/A
- Revenue
- GRWG $176,681,000.00
- SAVA N/A
- Revenue This Year
- GRWG N/A
- SAVA N/A
- Revenue Next Year
- GRWG $4.97
- SAVA N/A
- P/E Ratio
- GRWG N/A
- SAVA N/A
- Revenue Growth
- GRWG N/A
- SAVA N/A
- 52 Week Low
- GRWG $0.82
- SAVA $1.15
- 52 Week High
- GRWG $3.15
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- GRWG 47.60
- SAVA 56.59
- Support Level
- GRWG $1.09
- SAVA $1.45
- Resistance Level
- GRWG $1.24
- SAVA $1.67
- Average True Range (ATR)
- GRWG 0.11
- SAVA 0.11
- MACD
- GRWG 0.02
- SAVA 0.05
- Stochastic Oscillator
- GRWG 28.73
- SAVA 81.40
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.